Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-specific niflumic acid platinum(iv) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage
Linming Li, Ming Zhang, Dianlong Jia, et al.
Dalton Transactions (2022) Vol. 52, Iss. 1, pp. 147-158
Closed Access | Times Cited: 19

Showing 19 citing articles:

Development of Platinum Complexes for Tumor Chemoimmunotherapy
S. Jin, Yan Guo, Xiaoyong Wang
Chemistry - A European Journal (2024) Vol. 30, Iss. 10
Closed Access | Times Cited: 16
Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial–Mesenchymal Transition and Arousing Immune Response
Ming Zhang, Yan Chen, Zhifang Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 2031-2048
Closed Access | Times Cited: 14
Brij® integrated bilosomes for improving the transdermal delivery of niflumic acid for effective treatment of osteoarthritis: In vitro characterization, ex vivo permeability assessment, and in vivo study
Manar Adel Abdelbari, Amira A. El-Gazar, Aly A. Abdelbary, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123024-123024
Closed Access | Times Cited: 18
Canadine Platinum(IV) Complexes Targeting Epithelial–Mesenchymal Transition as Antiproliferative and Antimetastatic Agents
Yan Chen, Ming Zhang, Yan‐Qin He, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12868-12886
Closed Access | Times Cited: 5
Ursodeoxycholic Acid Platinum(IV) Conjugates as Antiproliferative and Antimetastatic Agents: Remodel the Tumor Microenvironment through Suppressing JAK2/STAT3 Signaling
Yan Chen, Ming Zhang, Zhifang Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 5
A series of ligustrazine platinum(iv) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects
Yan Chen, Linming Li, Zhifang Liu, et al.
Dalton Transactions (2023) Vol. 52, Iss. 37, pp. 13097-13109
Closed Access | Times Cited: 12
Autophagy-Targeted Platinum(IV) Agents: A New Horizon in Antitumor Drug Development
Suying Li, Yan Chen, Shuaiqi Feng, et al.
Dalton Transactions (2025)
Closed Access
Platinum‐Metformin Conjugates Acting as Promising PD‐L1 Inhibitors through the AMP‐Activated Protein Kinase Mediated Lysosomal Degradation Pathway
Bin Liu, Bing‐Bing Liang, Wan-Di Cao, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 49
Open Access | Times Cited: 3
Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial–Mesenchymal Transition Suppression, and Immune Activation Properties
Ming Zhang, Yan Chen, Shuaiqi Feng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16416-16434
Closed Access | Times Cited: 3
Hydrazylpyridine salicylaldehyde–copper(ii)–1,10-phenanthroline complexes as potential anticancer agents: synthesis, characterization and anticancer evaluation
Yating Chen, Zhilin Ke, Lingyu Yuan, et al.
Dalton Transactions (2023) Vol. 52, Iss. 35, pp. 12318-12331
Closed Access | Times Cited: 7
Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)
K. Jagathesan, Sovan Roy
ChemMedChem (2024) Vol. 19, Iss. 14
Closed Access | Times Cited: 2
Ciclopirox platinum(IV) conjugates suppress tumors by promoting mitophagy and provoking immune responses
Suying Li, Shuaiqi Feng, Yan Chen, et al.
Journal of Inorganic Biochemistry (2024) Vol. 260, pp. 112696-112696
Closed Access | Times Cited: 2
Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action
Daniil Spector, Anna Bubley, Елена К. Белоглазкина, et al.
Russian Chemical Reviews (2023) Vol. 92, Iss. 10, pp. RCR5096-RCR5096
Closed Access | Times Cited: 4
Synthesis and anticancer mechanisms of four novel platinum(ii) 4′-substituted-2,2′:6′,2′′-terpyridine complexes
Chun-Jie Liang, Run-Chun Wu, Xiaoqiong Huang, et al.
Dalton Transactions (2023) Vol. 53, Iss. 5, pp. 2143-2152
Closed Access | Times Cited: 4
Nanostructured mesoporous silica carriers for platinum-based conjugates with anti-inflammatory agents
Ivana Predarska, Goran N. Kaluđerović, Evamarie Hey‐Hawkins
Biomaterials Advances (2024) Vol. 165, pp. 213998-213998
Open Access | Times Cited: 1
Cetirizine platinum(IV) complexes with antihistamine properties inhibit tumor metastasis by suppressing angiogenesis and boosting immunity
Yan Chen, Shuaiqi Feng, Ming Zhang, et al.
Journal of Inorganic Biochemistry (2024) Vol. 262, pp. 112766-112766
Closed Access | Times Cited: 1
Pt(IV) derivatives of cisplatin and oxaliplatin bearing EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116
Zhong‐Ying Ma, Xiaojing Ding, Zhen-Zhen Zhu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 3239-3247
Closed Access
Platinum‐Metformin Conjugates Acting as Promising PD‐L1 Inhibitors through the AMP‐Activated Protein Kinase Mediated Lysosomal Degradation Pathway
Bin Liu, Bing‐Bing Liang, Wan-Di Cao, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 49
Closed Access
A Series of Ligustrazine Platinum(Iv) Complexes with Potent Anti-Proliferative and Anti-Metastatic Properties by Causing Chemotherapeutic and Immunotherapeutic Effects
Yan Chen, Linming Li, Zhifang Liu, et al.
(2023)
Closed Access
Page 1

Scroll to top